Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Crystallex (KRY) -- Ignore unavailable to you. Want to Upgrade?

To: tanoose who wrote (9911)	5/11/1999 12:33:00 AM
From: alan holman	Read Replies (2) \| Respond to of 10836

Monday May 10, 4:01 pm Eastern Time Company Press Release SOURCE: Crystallex International Corporation Crystallex Restructures Purchase Price of Inversora Mael; Procures US$6 Million Equity Line of Credit Financing VANCOUVER, British Columbia, May 10 /PRNewswire/ -- Crystallex International Corporation (Amex: KRY; Toronto) today announced the outstanding balance of the purchase price for its acquisition of Inversora Mael, through which it acquired title rights to the Cristinas 4 and 6 concessions, has been renegotiated and that Crystallex will use some of the proceeds from a new $US6 million equity line of credit in the restructured deal. As reported previously, Crystallex acquired the shares of Inversora Mael in March 1997 when Ventures (Barbados) Ltd. (Ventures), a private company held by two Crystallex directors, purchased the shares of Stay Management Ltd. (''Stay'') from Red Glove A.V.V. (''Red Glove''). The shares of Inversora Mael are the sole asset of Stay. Effective April 30, 1999, Ventures and Red Glove agreed to reduce the remaining portion of the purchase price from US$23.5 million to US$1O million plus 5 million warrants to Purchase Common Shares of Crystallex at a price of US$2.00 per share. The US$1O million is payable over time in cash or common shares of the Company. Also, Crystallex has entered into a US$6 million equity line of credit financing and has completed an initial draw down of approximately US$2 million. The draw down involves a private placement of convertible notes and common share purchase warrants. The 7% notes are convertible into common shares of the Company at a discount to the market price at the time of conversion. The warrants have an exercise price equal to 140% of the market price of the Company's common shares at the time the warrants are issued. A portion of the initial draw down is being used for certain payments related to the renegotiated Inversora Mael agreement. Marc J. Oppenheimer, President and Chief Executive Officer of Crystallex, commented that these are very positive developments for the Company. ''The new equity line of credit gives Crystallex more flexibility in continuing its growth strategy of internal development and acquiring producing or near production properties. The renegotiated agreement in regard to Inversora Mael is an initial step in the process of managing the costs involved in asserting our claim to title rights to the Cristinas 4 and 6 concessions,'' Oppenheimer said. Crystallex International Corporation is a gold mining and exploration company. The Company's strategy for growth is to develop its portfolio of properties in South America as well as to diversify geographically by investing in producing or near-production projects and by exploring properties of merit in other areas of the world. Note: This news release may contain certain ''forward-looking statements'' within the meaning of the United States Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, included in this release, including, without limitation, statements regarding potential mineralization and reserves, exploration results, and future plans and objectives of Crystallex, are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations are disclosed under the heading ''Risk Factors'' and elsewhere in documents filed from time to time with The Toronto Stock Exchange, the United States Securities and Exchange Commission and other regulatory authorities. The Toronto Stock Exchange has not reviewed this release and does not accept responsibility for the adequacy or accuracy of this news release. To receive previous Company releases: (800) 758-5804 ext. 114620. To receive press releases via e-mail contact the Company at info@crystallex.com . Visit the Company on the Internet: crystallex.com . SOURCE: Crystallex International Corporation